End of Day Message
LONDON, 13 May. 2025 (GLOBE NEWSWIRE) -- This is the End of Day Message for GlobeNewswire.
GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information provider.
Disclaimer
The content and accuracy of all information distributed through Notified is wholly the responsibility of the originator. Notified accepts no liability for any losses arising from reliance by any person upon the content of any announcement.
If you have any questions about this message, please Contact Us.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Report About the 1993 WWE Survivor Series Published by Pardu Productions
- XRP Price Prediction September 2026: Goldman Goes Big on XRP While Pepeto Targets 100x
- ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 14.3 months as 1st-line therapy in patients with HER2-mutant advanced non-small cell lung cancer in DESTI
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share